Global Biomarker Market Size By Type (Safety Biomarker, Efficacy Biomarker, Predictive Biomarker), By Product (Consumables, Services, Software), By Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders), By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine), By Geographic Scope And Forecast

Biomarker Market Size And Forecast

Biomarker Market size was valued at USD 46.38 Billion in 2020 and is projected to reach USD 130.16 Billion by 2028, growing at a CAGR of 13.77% from 2021 to 2028.

The Global Biomarker Market has witnessed increased demand in recent years, due to increasing diagnostic applications such as personalized medicine and companion diagnostics. The increasing collaborations and funds for R&D activities and the technological advancements collectively augmenting Biomarker Market growth across the globe. The Global Biomarker Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Biomarker Market Definition

A biomarker (biological marker) is a measurable indicator that captures what is happening in a cell or an organism at a given moment. In other words, they are used to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker is also known as a molecular marker or signature molecule, Biomarker, which is mainly found in blood, other body fluids, and tissue. Every biological system such as the cardiovascular system, metabolic system, or the immune system has its distinct biomarker and various Biomarker among these provides an ease to measure and became a part of routine medical examinations. Biomarkers allow pharmaceutical companies to analyze and discover novel drugs due to the increasing demand for cost-effective and efficient treatment doses is increasing.

An ideal biomarker has certain characteristics such as safe and easy to measure, cost-efficient to follow up, modifiable with treatment consistent across gender and ethnic groups. Biomarkers are used to predict serious illnesses such as diabetes and cardiovascular disease, cancer, neurological disorders, immunological disorders, and others. Every biomarker indicates whether there is a disease or health state and can be merged to provide a complete picture of how healthy a person is and if there is a requirement of diagnosis. Biomarkers are also used in imaging technology to provide clear imaging of oncology tumors and other problems and in clinical studies to determine the effect and results of drugs in an early stage. Biomarker plays a crucial role in disease risk assessment, drug discovery and development, diagnostics development, personalized medicine, and others.

Global Biomarker Market Overview

Factors such as the growing demand for personalized medicine and companion diagnostics are crucial growth drivers for the Global Biomarker Market. Increasing consumer awareness, a widening patient base, development of technologies in clinical laboratory tests, and imaging exams, are other major drivers of the Global Biomarker Market. The increasing number of cros and low cost of clinical trials in various developing economies has added fuel to the market growth. Additionally, the increasing R&D activities funded by pharmaceutical and biotechnology companies with the rising prevalence of cancer are major trends boosting the demand for biomarkers and thereby, accelerating the market growth.

The growing usage of Biomarkers in medical areas such as cancer treatment and research will foster the future growth of the Global Biomarker Market. There are three recent trends in the Global Biomarker Market. Biomarkers are identified conventionally by analyzing the science of pathophysiology and epidemiology, which is expected to transform the scenario of clinical research, medical practice, and drug development, due to changing technological advancement from the conventional approach of pathophysiology to biomarker studies such as genomics and proteomics. Heart diseases are the world’s leading cause of death, and the Asia Pacific holds a major share of coronary heart disease.

According to data published by the Ministry of Health in China, cardiovascular disease impacts negatively around 203 million people, and this number is anticipated to rise by 73 per cent in 2030. However, factors such as the need for huge capital for initial investment, unfavourable regulatory and repayment policies, high costs of tests, sample collection, and storage, and the low benefit-cost ratio are expected to restrain the market growth across the globe in the forecast period. Whereas, the increasing prevalence of cancer and the increasing investment in R&D by the potential market player is expected to offer lucrative opportunities for the Global Biomarker Market.

Global Biomarker MarketSegmentation Analysis

The Global Biomarker Market is segmented based on Type, Product, Disease Indication, Application, and Geography.

Biomarker Market, By Type

• Safety Biomarker• Efficacy Biomarker• Predictive Biomarker• Surrogate Biomarker• Pharmacodynamic Biomarker• Prognostic Biomarker• Validation Biomarker

Based on Type, the market is bifurcated into Safety biomarkers, Efficacy Biomarkers, Predictive Biomarkers, Surrogate biomarkers, Pharmacodynamic biomarkers, Prognostic biomarkers, and Validation Biomarkers. The safety Biomarker segment dominates the major market share in 2019 driven by increasing awareness regarding routine healthcare checkups and reduction in drug attrition.

Biomarker Market, By Product

• Consumables• Services• Software

Based on Product, the market is bifurcated into Consumables, Services, and Software. The consumable product holds the largest market share owing to the increasing awareness of the utilization of various devices to improve therapeutic procedures.

Biomarker Market, By Disease Indication

• Cancer• Cardiovascular Disorders• Neurological Disorders• Immunological Disorders• Other Diseases

Based on Disease Indication, the market is bifurcated into Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, and Other Diseases. The Cancer segment dominated the major market driven by a high disease burden and the presence of a strong pipeline.

Biomarker Market, By Application

• Diagnostics• Drug Discovery and Development• Personalized Medicine• Disease Risk Assessment• Other Applications

Based on Application, the market is bifurcated into Diagnostics, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, and Other Applications. The Drug Discovery and Development segment dominates the market majorly. This is due to the pharmaceutical and biotechnology companies are focusing more on extensive R&D initiatives for the development of targeted therapeutics.

Biomarker Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, the Global Biomarker Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America holds the largest market share followed by Europe, owing to the increasing adoption of Biomarkers in personalized medicine and investment by various potential players boosting the market growth in this region.

Key Players

The “Global Biomarker Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, and Signosis, Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations, and Agreements

• In June 2021, Akoya Biosciences and AstraZeneca said that they were collaborating on spatial biomarker analysis in immuno-oncology drug development, clinical trials, and biomarker discovery.

• In February 2021, INOVIO and QIAGEN expanded collaboration to develop next-gen sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia. QIAGEN’s bioinformatics expertise enhances predictive biomarker power in INOVIO’s patient selection.

Acquisition and Mergers

• In October 2020, Medidata acquired MC10’s digital biomarker business. Medidata said that this would help better integrate clinical-grade metrics into its remote trial platform and broadly support the use of wearable sensors for clinical research.

Product Launches and Product Expansions

• In April 2021, Amgen announced the launch of Biomarker Assist, a program to help more patients with metastatic non-small cell lung cancer (NSCLC) gain access to biomarker testing.

• In December 2020, Personalis announced the launch of NEOPS, a Neoantigen-based Composite Biomarker for Cancer immunotherapy response.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.